Detail akcie Integra Lifesci online

Business Summary: Integra LifeSciences Holdings Corporation is a global medical technology company. It manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). CSS consists of technologies and instrumentations used for specialties, such as neurosurgery, neurocritical care, and otolaryngology. CSS neurosurgical business includes a portfolio of brands, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. TT includes Wound Reconstruction and Care business, which sells offerings, such as skin and wound repair, plastics and surgical reconstruction products and nerve and tendon repair products. Its products include CUSA Platform, Codman Neurosurgical Accessories, DuraGen Dural Graft Matrix, DuraSeal Dural Sealant System and others.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2025, Integra Lifesciences Holdings Corp revenues increased 2% to $1.64B. Net loss increased from $6.9M to $516.5M. Revenues reflect Codman Specialty Surgical segment increase of 5% to $1.2B, Asia Pacific segment increase of 7% to $189.3M, United States segment increase of 1% to $1.2B, Europe segment increase of 3% to $162.7M.